Aktuellt
SENASTE
Redeye briefly comments on the news about the outcome of the rights issue. The subscription rate was 130%; thus, the rights issue was fully subscribed, and no issue guarantors were used. Moberg Pharma will receive SEK 100m before transaction costs.
LÄS MER
